Cognitive disease treatment trends
Signals
The Atlantic
An inventor at IBM has patented technology for a cognitive assistant that could learn all about you, then remind you of a name you can't remember the moment you need to say it.
Signals
PsyPost
One of the most intriguing physics discoveries of the last century was the existence of antimatter, material that exists as the “mirror image” of ...
Signals
IBTimes
Experts at Adelaide’s Flinders University have made an Alzheimer’s breakthrough that may result in world’s first dementia vaccine. Developed by Australian and US scientists, this vaccine may not only prevent but also reverse early stages of Alzheimer’s, the most common form of dementia.
Signals
Futurism
Contributions gained by ALS research groups from 2014's 'Ice Bucket Challenge' continue to lead to new, promising discoveries.
Signals
BBC
A drug for depression could stop all neurodegenerative diseases, including dementia, scientists hope.
Signals
Futurism
Researchers have constructed a laboratory model for a unique neurological disorder by transforming patients' own cells using stem cell technology.
Signals
Los Angeles Times
New research offers the prospect of limiting a stroke’s long-term damage with a drug that enhances the brain’s ability to rewire itself and promote recovery in the weeks and months after injury.
Signals
Newsweek
This finding is an important breakthrough in Alzheimer's research.
Signals
Nature
A man in his 50s is the first of seven patients to receive the experimental therapy. A man in his 50s is the first of seven patients to receive the experimental therapy.
Signals
Scientific American
Anxiety disorders, addiction, acute pain and stroke rehabilitation are just a few of the areas where VR therapy is already in use
Signals
New Scientist
Steve Dominy led a landmark study that linked gum disease bacteria to Alzheimer's disease. He tells New Scientist why we should stop treating medicine and dentistry separately
Signals
Scientific American
It may open the door to new treatments and explain why previous ones failed
Signals
Scitechdaily
McGill researchers' findings show that lithium may halt progression of Alzheimer's disease. There remains a controversy in scientific circles today regarding the value of lithium therapy in treating Alzheimer's disease. Much of this stems from the fact that because the information gathered to date
Signals
The New York Times
A surprising drug has brought a kind of consciousness to patients once considered vegetative — and changed the debate over pulling the plug.
Signals
Good News Network
The drugs metformin and bexarotene have been shown in trials to repair the myelin sheath in paitents with multiple sclerosis, or MS.
Signals
UCSF
Using standard animal model of Down syndrome, scientists were able to correct the learning and memory deficits associated with the condition with drugs that target the body’s response to cellular stresses.
Signals
New Atlas
We lose the ability to repair DNA damage as we age. But now a new study from MIT has found that reactivating a certain enzyme improves repair of DNA damage in neurons, which helps Alzheimer’s patients and others with cognitive decline.
Signals
Inverse
Scientists examine the "engine for consciousness."
Signals
Singularity Hub
It’s been hard to accurately replicate the behavior of neurons in silicon because the way they respond to stimuli is non-linear.
Signals
Quanta Magazine
A brain circuit that suppresses distracting sensory information holds important clues about attention and other cognitive processes.
Signals
Qualia Computing
Reposted from Enthea with permission from the writer: Drs. Robin Carhart-Harris and Karl Friston recently published a beautiful paper – REBUS and the Anarchic Brain (a). It's great for two reasons: It presents a plausible unified theory of how psychedelics work. It's a wonderful jumping-off point into the literature. Every paragraph is full of pointers to research that's…
Signals
Science Daily
Researchers used MRI brain scans and machine learning techniques at birth to predict cognitive development at age 2 years with 95 percent accuracy.
Signals
TEDx Talks
Neurotechnology has the potential to influence what we remember and what we forget, what we feel and perceive, even what we think and believe. Matthew Liao i...
Signals
The Atlantic
Lou Ortenzio was a trusted West Virginia doctor who got his patients—and himself—hooked on opioids. Now he’s trying to rescue his community from an epidemic he helped start.
